Antithrombotic benefits and hemorrhagic risks of direct thrombin antagonists

Thromb Haemost. 1995 Jul;74(1):464-72.
No abstract available

Publication types

  • Review

MeSH terms

  • Amino Acid Sequence
  • Animals
  • Antithrombins / administration & dosage
  • Antithrombins / adverse effects
  • Antithrombins / therapeutic use*
  • Blood Platelets / physiology
  • Hemorrhage / chemically induced*
  • Hirudin Therapy
  • Hirudins / adverse effects
  • Hirudins / analogs & derivatives
  • Humans
  • Molecular Sequence Data
  • Papio
  • Peptide Fragments / adverse effects
  • Peptide Fragments / therapeutic use
  • Platelet Aggregation Inhibitors / adverse effects
  • Platelet Aggregation Inhibitors / therapeutic use*
  • Platelet Glycoprotein GPIIb-IIIa Complex / antagonists & inhibitors
  • Platelet Glycoprotein GPIIb-IIIa Complex / physiology
  • Primates
  • Recombinant Proteins / adverse effects
  • Recombinant Proteins / therapeutic use
  • Thrombin / physiology
  • Thrombosis / drug therapy*

Substances

  • Antithrombins
  • Hirudins
  • Peptide Fragments
  • Platelet Aggregation Inhibitors
  • Platelet Glycoprotein GPIIb-IIIa Complex
  • Recombinant Proteins
  • Thrombin
  • bivalirudin